Showing 3 of 3 results
"What Took Us Years Could Now Take Half the Time": Innovation Is Redefining Pharma
AI and other technologies have significantly shortened the R&D process in the pharma industry. Dr. Eran Harary of Teva Pharmaceuticals sheds light on innovation.
New R&D Facility in Hungary will Double Annual Testing Capability
Go behind the scenes at Teva to Debrecen in Hungary, where a new $2.4 million R&D facility is helping to speed up production and get medicines to patients faster
Democratizing Science: Big Pharma Joins Forces with Academia
Building cross-sector and multidisciplinary collaborations, developing innovative technology and supporting the next generation of entrepreneurs will all play an important part in developing the medicines of the future. An industry shift in attitudes and working patterns is needed to embrace this new age and find new ways of operating. At Teva, this shift has already started.